TrialDrugs in R&D2018

Two Glucose-Lowering Mechanisms of Canagliflozin Depending on Body Weight Changes in Drug-Naïve Subjects with Type 2 Diabetes.

Eiji Kutoh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.